CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, and relapsed or refractory natural killer/T cel...
Industry: Biotechnology
Sector: Healthcare
Phone: 86 512 8718 6550
Address:
C1 Building, No. 218 Xinghu Street North Block Suzhou Industrial Park, Suzhou, China
